Venture Capital

Tethered drone leader Hoverfly partners with Korea's KRM to tackle a critical U.S. defense vulnerability: the nation's reliance on Chinese drone parts.

The visual app giant's pivot to AI agents drove a 65% profit surge and captured high-value global markets, redefining its future and business model.

The new AI model generates multi-shot films with sound from a single prompt, challenging rivals and pushing deeper into enterprise automation.

The purchase of IronHQ marks Perseus's 11th dealer software deal, reinforcing a broader strategy of dominating niche vertical software markets.

The biotech firm's oversubscribed funding round will accelerate its universal flu shot and a diverse pipeline targeting cancer, malaria, and Alzheimer's.

In a strategic move to dominate the AI infrastructure boom, AVAIO Digital has hired industry pioneer Jason Norado to execute its multi-gigawatt expansion.

Phase 2 data for HRS/BHB-1893 show rapid efficacy and a simplified regimen, signaling a potential new era for treating hypertrophic cardiomyopathy.

German CDMO Vetter wins a prestigious, client-voted award, underscoring its pivotal role and massive €2 billion investment in the world of injectable biologics.

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

Amid a tough biotech market, the firm extends its cash runway to 2027, accelerating development of its promising rademikibart treatment for respiratory diseases.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.

As millions grapple with Cannabis Use Disorder, a small biotech's lead drug enters Phase 3 trials, promising the first-ever FDA-approved treatment.

Starcloud is now Y Combinator's fastest unicorn. Its audacious plan to build data centers in orbit has attracted top VCs and sparked a new space race for AI.

Magnachip's new power semiconductors promise major efficiency and density gains for servers, tackling the soaring energy needs of the growing AI boom.

At MCE 2026, Midea unveiled a bold new strategy, shifting from products to a full-service ecosystem designed to empower installers and drive a green future.

China's literary giant Yuewen leverages AI and a new generation of creators to build a global IP empire, from novels to AI-dramas and merchandise.

Global CRO ChemPartner launches a new research site in Kent's Discovery Park, a major strategic push to accelerate drug development for European clients.

Highstar launches China's first overseas tabless battery factory in Malaysia, unveiling a high-performance cell for tools, robots, and future eVTOLs.